Investor Event

RNS Number : 8042R
Microsaic Systems plc
05 March 2019
 

05 March 2019

Microsaic Systems plc

("Microsaic" or the "Company")

 

Investor Event

 

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments announces that it will be hosting an investor event on 11 March 2019.

 

The event will be held at Davy's at Woolgate Bar and Brasserie, 25 Basinghall St, London EC2V 5HA from 5.30pm and will take the form of a Company presentation to discuss the annual results followed by a Q&A session, finishing at 8.00pm.

The event is primarily aimed at the private client broker and retail investor communities.

Investors and shareholders who wish to attend the event should register their interest by visiting the link below:

https://www.eventbrite.com/o/microsaic-systems-plc-19343479112

 

Enquiries:

 


Microsaic Systems plc

Glenn Tracey, CEO

Bevan Metcalf, FD

+44 (0) 1483 751 577

 

N+1 Singer (Nominated Adviser & Broker)

Shaun Dobson / George Tzimas (Corporate Finance)

Tom Salvesen (Corporate Broking)

 

 

+44 (0)20 7496 3000

IFC Advisory Ltd (Financial PR)

Graham Herring

Heather Armstrong

Florence Chandler

+44 (0)20 3934 6630

 

 

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing. The Company works with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines.  MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

 

The Microsaic's compact MiD® MS systems retain the functionality of larger conventional MS systems, while being easier to use by non-specialists, and consume less energy and have lower running costs. For more information, please go to www.microsaic.com.  

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAUSSBRKVAORAR
UK 100

Latest directors dealings